{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T19:25:33Z","timestamp":1774639533773,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,8,24]],"date-time":"2013-08-24T00:00:00Z","timestamp":1377302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl."],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00103-013-1789-z","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T10:42:08Z","timestamp":1377772928000},"page":"1313-1320","source":"Crossref","is-referenced-by-count":22,"title":["Die Varizellenimpfung in Deutschland","Varicella vaccination in Germany"],"prefix":"10.1007","volume":"56","author":[{"given":"A.","family":"Siedler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Rieck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tolksdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,24]]},"reference":[{"key":"1789_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/S0950268800004714","volume":"125","author":"Brisson","year":"2000","unstructured":"Brisson M, Edmunds WJ, Gax NJ et al (2000) Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 125:19","journal-title":"Epidemiol Infect"},{"key":"1789_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0264-410X(02)00382-1","volume":"20","author":"Brisson","year":"2002","unstructured":"Brisson M, Gay NJ, Edmunds WJ, Andrews NJ (2002) Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 20:8","journal-title":"Vaccine"},{"key":"1789_CR3","first-page":"10","volume":"139","author":"Hoehle","year":"2011","unstructured":"Hoehle M, Siedler A, Bader HM et al (2011) Assessment of varicella vaccine effectiveness in Germany: a time-series approach. Epidemiol Infect 139:10","journal-title":"Epidemiol Infect"},{"key":"1789_CR4","first-page":"6","volume":"191","author":"Jumaan","year":"2002","unstructured":"Jumaan AO, Yu O, Jackson LA et al (2002) Incidence of herpes zoster, before and after varicella-vaccination \u2013 associated decreases in the incidence of varicella, 1992\u20132002. J Infect Dis 191:6","journal-title":"J Infect Dis"},{"key":"1789_CR5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/adc.2010.206037","volume":"96","author":"Khandaker","year":"2011","unstructured":"Khandaker G, Marshall H, Peadon E et al (2011) Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Arch Dis Child 96:4","journal-title":"Arch Dis Child"},{"key":"1789_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cid\/ciq077","volume":"52","author":"Leung","year":"2011","unstructured":"Leung J, Harpaz R, Molinari NA et al (2011) Herpes zoster incidence among insured persons in the United States, 1993\u20132006: evaluation of impact of varicella vaccination. Clin Infect Dis 52:9","journal-title":"Clin Infect Dis"},{"key":"1789_CR7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1086\/527419","volume":"197","author":"Lopez","year":"2008","unstructured":"Lopez AS, Kolasa MS, Seward JF (2008) Status of school entry requirements for varicella vaccination and vaccination coverage 11 years after implementation of the varicella vaccination program. J Infect Dis 197:6","journal-title":"J Infect Dis"},{"key":"1789_CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/522155","volume":"197","author":"Marin","year":"2008","unstructured":"Marin M, Watson TL, Chaves SS et al (2008) Varicella among adults: data from an active surveillance project, 1995\u20132005. J Infect Dis 197:7","journal-title":"J Infect Dis"},{"key":"1789_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/INF.0b013e3181d9f657","volume":"29","author":"Nguyen","year":"2010","unstructured":"Nguyen MD, Perella D, Watson B et al (2010) Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in philadelphia, pennsylvania, 2006. Pediatr Infect Dis J 29:5","journal-title":"Pediatr Infect Dis J"},{"key":"1789_CR10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2458-10-502","volume":"10","author":"Reuss","year":"2010","unstructured":"Reuss AM, Feig M, Kappelmayer L et al (2010) Varicella vaccination coverage of children under two years of age in Germany. BMC Public Health 10:7","journal-title":"BMC Public Health"},{"key":"1789_CR11","first-page":"5","volume":"16","author":"Robert-Koch-Institut","year":"2012","unstructured":"Robert-Koch-Institut (2012) Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2010. Epid Bull 16:5","journal-title":"Epid Bull"},{"key":"1789_CR12","unstructured":"Robert-Koch-Institut SurvStat@RKI (o J) Abfrage der Meldedaten nach Infektionsschutzgesetz (IfSG) \u00fcber das Web. http:\/\/www.rki.de\/DE\/Content\/Infekt\/SurvStat\/survstat_node.html"},{"key":"1789_CR13","first-page":"9","volume":"8","author":"Robert-Koch-Institut","year":"2008","unstructured":"Robert-Koch-Institut (2008) Zur Sentinel-Surveillance der Varizellen in Deutschland. Epid Bull 8:9","journal-title":"Epid Bull"},{"key":"1789_CR14","first-page":"6","volume":"287","author":"Seward","year":"2002","unstructured":"Seward J, Watson B, Peterson C et al (2002) Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000. JAMA 287:6","journal-title":"JAMA"},{"key":"1789_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2807\/ese.15.13.19530-en","volume":"15","author":"Siedler","year":"2010","unstructured":"Siedler A, Arndt U (2010) Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill 15:7","journal-title":"Euro Surveill"},{"key":"1789_CR16","unstructured":"Siedler A, Grueber A (2012) Effect of second varicella vaccine dose on breakthrough cases in Germany \u2013 preliminary results from sentinel surveillance. 30th Annual Meeting of the European Society For Paediatric Infectious Diseases"},{"key":"1789_CR17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2807\/ese.17.17.20152-en","volume":"17","author":"Siedler","year":"2012","unstructured":"Siedler A, Rieck T, Reuss A et al (2012) Estimating vaccination coverage in the absence of immunisation registers \u2013 the German experience. Euro Surveill 17:7","journal-title":"Euro Surveill"},{"key":"1789_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/INF.0b013e3181e2817f","volume":"29","author":"Spackova","year":"2010","unstructured":"Spackova M, Muehlen M, Siedler A (2010) Complications of varicella after implementation of routine childhood varicella vaccination in Germany. Pediatr Infect Dis J 29:3","journal-title":"Pediatr Infect Dis J"},{"key":"1789_CR19","first-page":"6","volume":"28","author":"Spackova","year":"2010","unstructured":"Spackova M, Wiese-Posselt M, Dehnert M et al (2010) Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine 28:6","journal-title":"Vaccine"},{"key":"1789_CR20","unstructured":"Statistisches-Bundesamt (o J) Das Informationssystem der Gesundheitsberichterstattung des Bundes. http:\/\/www.gbe-bund.de"},{"key":"1789_CR21","first-page":"4","volume":"49","author":"STIKO","year":"2004","unstructured":"STIKO (2004) Begr\u00fcndung der STIKO f\u00fcr eine allgemeine Varizellenimpfung. Epid Bull 49:4","journal-title":"Epid Bull"},{"key":"1789_CR22","first-page":"28","volume":"30","author":"STIKO","year":"2012","unstructured":"STIKO (2012) Empfehlungen der St\u00e4ndigen Impfkommision. Stand Juli 2012. Epid Bull 30:28","journal-title":"Epid Bull"},{"key":"1789_CR23","first-page":"16","volume":"30","author":"STIKO","year":"2004","unstructured":"STIKO (2004) Empfehlungen der St\u00e4ndigen Impfkommission, Stand Juli 2004. Epid Bull 30:16","journal-title":"Epid Bull"},{"key":"1789_CR24","first-page":"20","volume":"30","author":"STIKO","year":"2006","unstructured":"STIKO (2006) Empfehlungen der St\u00e4ndigen Impfkommission, Stand Juli 2006. Epid Bull 30:20","journal-title":"Epid Bull"},{"key":"1789_CR25","first-page":"20","volume":"30","author":"STIKO","year":"2009","unstructured":"STIKO (2009) Empfehlungen der St\u00e4ndigen Impfkommission, Stand Juli 2009. Epid Bull 30:20","journal-title":"Epid Bull"},{"key":"1789_CR26","first-page":"1","volume":"41","author":"STIKO","year":"2008","unstructured":"STIKO (2008) Mitteilung der St\u00e4ndigen Impfkommission (STIKO) am RKI zur Impfung gegen Varizellen. Epid Bull 41:1","journal-title":"Epid Bull"},{"key":"1789_CR27","first-page":"2","volume":"38","author":"STIKO","year":"2011","unstructured":"STIKO (2011) Mitteilung der St\u00e4ndigen Impfkommission: Zur Kombinationsimpfung gegen Masern, Mumps, R\u00f6teln und Varizellen (MMRV). Epid Bull 38:2","journal-title":"Epid Bull"},{"key":"1789_CR28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/INF.0b013e318260cc4d","volume":"31","author":"Tan","year":"2012","unstructured":"Tan B, Bettinger J, McConnell A et al (2012) The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000\u20132008. Pediatr Infect Dis J 31:8","journal-title":"Pediatr Infect Dis J"},{"key":"1789_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1128\/CVI.05021-11","volume":"18","author":"Thiele","year":"2011","unstructured":"Thiele S, Borschewski A, K\u00fcchler J et al (2011) Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions. Clin Vaccine Immunol 18:9","journal-title":"Clin Vaccine Immunol"},{"key":"1789_CR30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1128\/JVI.00777-08","volume":"82","author":"Tillieux","year":"2008","unstructured":"Tillieux SL, Halsey WS, Thomas ES et al (2008) Complete DNA sequences of two oka strain varicella-zoster virus genomes. J Virol 82:12","journal-title":"J Virol"},{"key":"1789_CR31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vaccine.2011.04.008","volume":"29","author":"Hoek","year":"2011","unstructured":"Hoek AJ van, Melegaro A, Zagheni E et al (2011) Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine 29:10","journal-title":"Vaccine"},{"key":"1789_CR32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2458-5-68","volume":"5","author":"Yih","year":"2005","unstructured":"Yih WK, Brooks DR, Lett SM et al (2005) The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998\u20132003. BMC Public Health 5:9","journal-title":"BMC Public Health"},{"key":"1789_CR33","doi-asserted-by":"crossref","unstructured":"Streng A, Grote V, Carr D, Hagemann C, Liese JG (2013) Varicella routine vaccination and the effects on varicella epidemiology \u2013 results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006\u20132011. BMC Infect Dis 2;13(1):303","DOI":"10.1186\/1471-2334-13-303"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-013-1789-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-013-1789-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-013-1789-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-013-1789-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T02:55:28Z","timestamp":1646448928000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-013-1789-z"}},"subtitle":["Eine Zwischenbilanz mit Blick auf die Masern-Mumps-R\u00f6teln- (MMR-)Impfung","A provisional appraisal in the context of MMR vaccination"],"short-title":[],"issued":{"date-parts":[[2013,8,24]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["1789"],"URL":"https:\/\/doi.org\/10.1007\/s00103-013-1789-z","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,24]]}}}